Related references
Note: Only part of the references are listed.Nucleoside Reverse Transcriptase Inhibitor Interaction with Human Equilibrative Nucleoside Transporters 1 and 2
Siennah R. Miller et al.
DRUG METABOLISM AND DISPOSITION (2020)
Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19
Richard T. Eastman et al.
ACS CENTRAL SCIENCE (2020)
Clinical Characteristics and Results of Semen Tests Among Men With Coronavirus Disease 2019
Diangeng Li et al.
JAMA NETWORK OPEN (2020)
SARS-CoV-2 and the testis: similarity with other viruses and routes of infection
Walter D. Cardona Maya et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2020)
Non-enzymatic Lysine Lactoylation of Glycolytic Enzymes
Dominique O. Gaffney et al.
CELL CHEMICAL BIOLOGY (2020)
Multiple Machine Learning Comparisons of HIV Cell-based and Reverse Transcriptase Data Sets
Kimberley M. Zorn et al.
MOLECULAR PHARMACEUTICS (2019)
Contribution of equilibrative nucleoside transporters 1 and 2 to gemcitabine uptake in pancreatic cancer cells
Masato Hioki et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2018)
Comparing and Validating Machine Learning Models for Mycobacterium tuberculosis Drug Discovery
Thomas Lane et al.
MOLECULAR PHARMACEUTICS (2018)
Assessment of Substrate-Dependent Ligand Interactions at the Organic Cation Transporter OCT2 Using Six Model Substrates
Philip J. Sandoval et al.
MOLECULAR PHARMACOLOGY (2018)
Comparing Multiple Machine Learning Algorithms and Metrics for Estrogen Receptor Binding Prediction
Daniel P. Russo et al.
MOLECULAR PHARMACEUTICS (2018)
Transepithelial transport across the blood-testis barrier
Siennah R. Miller et al.
REPRODUCTION (2018)
Human equilibrative nucleoside transporter 1 (hENT1) expression as a predictive biomarker for gemcitabine chemotherapy in biliary tract cancer
Jaihwan Kim et al.
PLOS ONE (2018)
Contribution of equilibrative nucleoside transporter(s) to intestinal basolateral and apical transports of anticancer trifluridine
Koichi Takahashi et al.
BIOPHARMACEUTICS & DRUG DISPOSITION (2018)
Equilibrative nucleoside transportersA review
Rebba C. Boswell-Casteel et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2017)
Human equilibrative nucleoside transporter 1 gene expression is associated with gemcitabine efficacy in advanced leiomyosarcoma and angiosarcoma
Bruno Vincenzi et al.
BRITISH JOURNAL OF CANCER (2017)
FLT3 is implicated in cytarabine transport by human equilibrative nucleoside transporter 1 in pediatric acute leukemia
Albert Catala et al.
ONCOTARGET (2016)
The Mammalian Blood-Testis Barrier: Its Biology and Regulation
Dolores D. Mruk et al.
ENDOCRINE REVIEWS (2015)
Open Source Bayesian Models. 1. Application to ADME/Tox and Drug Discovery Datasets
Alex M. Clark et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)
Open Source Bayesian Models. 2. Mining a Big Dataset To Create and Validate Models with ChEMBL
Alex M. Clark et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2015)
Saturable Hepatic Extraction of Gemcitabine Involves Biphasic Uptake Mediated by Nucleoside Transporters Equilibrative Nucleoside Transporter 1 and 2
Takuya Shimada et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Nucleoside transporter proteins as biomarkers of drug responsiveness and drug targets
Marcal Pastor-Anglada et al.
FRONTIERS IN PHARMACOLOGY (2015)
HIV and the spectrum of human disease
Sebastian Lucas et al.
JOURNAL OF PATHOLOGY (2015)
Nucleoside transporters and human organic cation transporter 1 determine the cellular handling of DNA-methyltransferase inhibitors
C. Arimany-Nardi et al.
BRITISH JOURNAL OF PHARMACOLOGY (2014)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
Advances in the development of nucleoside and nucleotide analogues for cancer and viral diseases
Lars Petter Jordheim et al.
NATURE REVIEWS DRUG DISCOVERY (2013)
The Role of Human Equilibrative Nucleoside Transporter 1 on the Cellular Transport of the DNA Methyltransferase Inhibitors 5-Azacytidine and CP-4200 in Human Leukemia Cells
Johanna Hummel-Eisenbeiss et al.
MOLECULAR PHARMACOLOGY (2013)
Basolateral Uptake of Nucleosides by Sertoli Cells Is Mediated Primarily by Equilibrative Nucleoside Transporter 1
David M. Klein et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2013)
The role of transporters in the toxicity of nucleoside and nucleotide analogs
Christopher A. Koczor et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2012)
ROLE OF HUMAN NUCLEOSIDE TRANSPORTERS IN THE UPTAKE AND CYTOTOXICITY OF AZACITIDINE AND DECITABINE
Vijaya L. Damaraju et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2012)
Human Equilibrative Nucleoside Transporter 1 (hENT1) Levels Predict Response to Gemcitabine in Patients With Biliary Tract Cancer (BTC)
D. Santini et al.
CURRENT CANCER DRUG TARGETS (2011)
Profiling of a Prescription Drug Library for Potential Renal Drug-Drug Interactions Mediated by the Organic Cation Transporter 2
Yasuto Kido et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Emerging role for drug transporters at the blood-testis barrier
Dolores D. Mruk et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2011)
HIV infection of the male genital tract - consequences for sexual transmission and reproduction
A. Le Tortorec et al.
INTERNATIONAL JOURNAL OF ANDROLOGY (2010)
Membrane transporters in drug development
Kathleen M. Giacomini et al.
NATURE REVIEWS DRUG DISCOVERY (2010)
Transport of Nucleoside Analogs Across the Plasma Membrane: A Clue to Understanding Drug-Induced Cytotoxicity
I. Huber-Ruano et al.
CURRENT DRUG METABOLISM (2009)
Nucleoside analogs: molecular mechanisms signaling cell death
B. Ewald et al.
ONCOGENE (2008)
The role of human nucleoside transporters in cellular uptake of 4′-thio-β-D-arabinofuranosylcytosine and β-D-arabinosylcytosine
Marilyn L. Clarke et al.
MOLECULAR PHARMACOLOGY (2006)
A comparison of the transportability, and its role in cytotoxicity, of clofarabine, cladribine, and fludarabine by recombinant human nucleoside transporters produced in three model expression systems
KM King et al.
MOLECULAR PHARMACOLOGY (2006)
Nucleoside transport at the blood-testis barrier studied with primary-cultured Sertoli cells
R Kato et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Topology of a human equilibrative, nitrobenzylthioinosine (NBMPR)-sensitive nucleoside transporter (hENT1) implicated in the cellular uptake of adenosine and anti-cancer drugs
M Sundaram et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Transport of antiviral 3′-deoxy-nucleoside drugs by recombinant human and rat equilibrative, nitrobenzylthioinosine (NBMPR)-insensitive (ENT2) nucleoside transporter proteins produced in Xenopus oocytes
SYM Yao et al.
MOLECULAR MEMBRANE BIOLOGY (2001)
Abacavir - A review of its clinical potential in patients with HIV infection
PS Hervey et al.
DRUGS (2000)
Kinetic and pharmacological properties of cloned human equilibrative nucleoside transporters, ENT1 and ENT2, stably expressed in nucleoside transporter-deficient PK15 cells - ENT2 exhibits a low affinity for guanosine and cytidine but a high affinity for inosine
JL Ward et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
